今日の臨床サポート 今日の臨床サポート
関連論文:
img  1:  Results of the national pilot screening program for venous disease by the American Venous Forum.
 
著者: Robert B McLafferty, Joanne M Lohr, Joseph A Caprini, Marc A Passman, Frank T Padberg, Thom W Rooke, Ruth L Bush, Aamir A Zakaria, William R Flinn, Bo G Eklof, Michael C Dalsing, Steven J Markwell, Thomas W Wakefield
雑誌名: J Vasc Surg. 2007 Jan;45(1):142-148. doi: 10.1016/j.jvs.2006.08.079.
Abstract/Text OBJECTIVE: This report describes the pilot of a free comprehensive national screening program for venous disease.
METHODS: The screening process consisted of a venous thromboembolism (VTE) risk assessment, abbreviated duplex examination for venous obstruction and reflux, inspection for signs of chronic venous insufficiency (CVI), and an exit interview. Physicians coordinating the screenings were members of the American Venous Forum.
RESULTS: Seventeen institutions screened 476 people (mean, 28 per site; range, 6 to 71). Mean age was 60 years (range, 40 to 91 years), with 78% women and 68% with a body mass index of > or =25. If placed in a situation conducive for VTE, 22 participants (5%) were low risk, 87 (18%) were moderate risk, 186 (39%) were high risk, and 179 (38%) were at very high risk. In 26 people (6%), one or more segments had venous obstruction, and 190 (40%) had one or more segments of venous reflux in the lower extremities. Varicose veins were present in 32%, edema without skin changes in 11%, skin changes attributable to venous disease in 8%, and healed or active venous stasis ulcer in 1.3% (CEAP classification 2, 3, 4, 5, and 6, respectively). Increasing age and increasing deep venous thrombosis risk score significantly correlated with increasing clinical classification, r = 0.09, P = .04, and r = 0.16, P = .0004, respectively. Those participants with reflux in one or more segments were significantly more likely to have a higher clinical classification compared with those with no reflux (P = .0001).
CONCLUSION: The first comprehensive national screening for venous disease was performed. Participants were informed of their risk for VTE if placed in a situation conducive to VTE, screened for evidence of obstruction, reflux, and CVI, and empowered to share their results with their primary care provider.

PMID 17210399  J Vasc Surg. 2007 Jan;45(1):142-148. doi: 10.1016/j.jvs.2006.08.079.
戻る

さらなるご利用にはご登録が必要です。

こちらよりご契約または優待日間無料トライアルお申込みをお願いします。

(※トライアルご登録は1名様につき、一度となります)


ご契約の場合はご招待された方だけのご優待特典があります。

以下の優待コードを入力いただくと、

契約期間が通常12ヵ月のところ、14ヵ月ご利用いただけます。

優待コード: (利用期限:まで)

ご契約はこちらから